Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01764113 · ClinicalTrials.gov registry record · Phase 3

Effect of Mindful Eating on Body Mass Index in Obese Adolescents

A Phase 3 study of Adolescent Obesity, sponsored by Mayo Clinic.

Completed
Registry status
Phase 3
Development phase
21
Enrollment target
1
Study location

NCT01764113: Completed Phase 3 study of Adolescent Obesity, sponsored by Mayo Clinic.

NCT01764113 is a Phase 3 study of Adolescent Obesity that has completed, run by Mayo Clinic. The registered enrollment target is 21 participants, below the 75-participant average among 12 other Adolescent Obesity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01764113, a Phase 3 study of Adolescent Obesity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 3
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

This study is designed to study the effect of a family based mindfulness training program with special focus on diet and nutrition on weight and cardiovascular risk markers in obese adolescents.

Primary Outcome

Body Mass Index would be calculated at baseline, at 3 months and at 6 months

Conditions Studied

Interventions

  • BEHAVIORAL Mindful Eating
  • BEHAVIORAL Standard dietary counselling

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2012-12
Est. Completion 2013-12
Phase Phase 3
Mayo Clinic

2,844 total trials

What the finished NCT01764113 record still lists

NCT01764113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 75-participant average among 12 other Adolescent Obesity trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Adolescent Obesity appearing as the primary indexed condition, and to 2 interventions - of which Mindful Eating is the first listed.

NCT01764113 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01764113 about?

NCT01764113 is a clinical study titled "Effect of Mindful Eating on Body Mass Index in Obese Adolescents". This study is designed to study the effect of a family based mindfulness training program with special focus on diet and nutrition on weight and cardiovascular risk markers in obese adolescents.

What is the current status of trial NCT01764113?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 21 participants. The study started on 2012-12. Estimated completion is 2013-12.

What conditions does trial NCT01764113 study?

This clinical trial studies the following conditions: Adolescent Obesity.

What interventions are being tested in trial NCT01764113?

The interventions under investigation include: Mindful Eating (BEHAVIORAL), Standard dietary counselling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01764113?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01764113 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adolescent Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01764113's enrollment target sits among peer trials

21 12th of 12 higher than 1 of 12 other Adolescent Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Adolescent Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01764113, the US trial registry maintained by the National Library of Medicine. NCT01764113 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.